Atlas Trials

Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron

Clinical trial NCT01950247 · COMPLETED

Trial details

NCT number
NCT01950247
Sponsor
American Regent, Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Iron Deficiency Anemia (IDA)
Start date
2013-08-15
Primary completion
2015-05-20
Enrollment
1025

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.